Rating History for EPIRUS Biopharmaceuticals (EPRS) by Leerink

More Stocks Rated by Leerink | Latest Ratings for EPRS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/16/2016 N/A Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 0.78
(0.14)		 -82.05% Details